Detalhe da pesquisa
1.
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3ß/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's Disease.
ACS Chem Neurosci
; 15(11): 2099-2111, 2024 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747979
2.
Chrysin bonded to ß-d-glucose tetraacetate enhances its protective effects against the neurotoxicity induced by aluminum in Swiss mice.
J Pharm Pharmacol
; 76(4): 368-380, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330395
3.
PROTAC-Induced Glycogen Synthase Kinase 3ß Degradation as a Potential Therapeutic Strategy for Alzheimer's Disease.
ACS Chem Neurosci
; 14(11): 1963-1970, 2023 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218653